Clinical Biomarker Study of the Tumor NLRP3 Inflammasome and its Role in Anti-PD-1 Immunotherapy Resistance
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Conquer Cancer Foundation
Start Date
July 1, 2021
End Date
December 31, 2024
Administered By
Medicine, Medical Oncology
Awarded By
Conquer Cancer Foundation
Start Date
July 1, 2021
End Date
December 31, 2024